Artemether-Lumefantrine designated as first malaria treatment for newborns and young infants

Author: tanzaniatimes.netPublished on: April 27, 2026Country: Tanzania

Health

Artemether-Lumefantrine designated as first malaria treatment for newborns and young infants

The World Health Organization has prequalified artemether-lumefantrine as the first antimalarial treatment specifically designed for newborns and young infants weighing between two and five kilograms. This designation will improve access to quality treatment for approximately 30 million babies born each year in malaria-endemic areas of Africa. Dr. Tedros Adhanom Ghebreyesus stated that this advancement marks a significant change in the fight against malaria.

Stay informed with NewsBoulevard

Get the latest news summaries delivered to your inbox

Related News

Crucial Week of Talks at WHO as Vaccine Access, Data Sharing Divide Nations

PoliticsHealthMorocco

Zayneb Elasraoui•24m ago

Crucial Week of Talks at WHO as Vaccine Access, Data Sharing Divide Nations

A round of negotiations has opened this week at the World Health Organization (WHO) to resolve disputes over vaccine access and pathogen sharing under a global pandemic treaty. Although a treaty was adopted in May 2025, key issues remain unresolved, including the proposed PABS system to regulate the exchange of biological samples and genetic data. Developing countries express concerns about fair access to vaccines, while wealthier nations question the financial incentives needed to support such a system.

Africa: First Malaria Drug for Newborns Gets Who Approval

HealthRwanda

Joan Mbabazi•25m ago

Africa: First Malaria Drug for Newborns Gets Who Approval

The World Health Organization (WHO) approved the first malaria treatment designed for newborns and very young infants on April 24, 2026. The medicine, artemether-lumefantrine, is intended for babies weighing between two and five kilograms, allowing for more appropriate treatment. This approval aims to close a care gap, especially in Africa, where around 30 million babies are born each year in malaria-affected areas.

Insurance shows up real-life odds of thriving after a cancer diagnosis

HealthSouth Africa

Brendan Dunn•1h ago

Insurance shows up real-life odds of thriving after a cancer diagnosis

A recent study highlights the impact of insurance policies on survival odds after a cancer diagnosis. Data shows that patients with adequate coverage have better treatment and recovery prospects. This underscores the importance of appropriate health insurance in managing serious illnesses.

Stay Updated with NewsBoulevard

Subscribe to our newsletter for the latest news summaries delivered to your inbox

Learn more